PTC Therapeutics, Inc. (PTCT)
NASDAQ: PTCT · Real-Time Price · USD
70.26
+1.04 (1.50%)
At close: Apr 28, 2026, 4:00 PM EDT
71.20
+0.94 (1.34%)
After-hours: Apr 28, 2026, 7:54 PM EDT
PTC Therapeutics Employees
PTC Therapeutics had 991 employees as of December 31, 2025. The number of employees increased by 52 or 5.54% compared to the previous year.
Employees
991
Change (1Y)
52
Growth (1Y)
5.54%
Revenue / Employee
$1,746,372
Profits / Employee
$688,844
Market Cap
5.83B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 991 | 52 | 5.54% | 991 | 0 |
| Dec 31, 2024 | 939 | -116 | -11.00% | 939 | 0 |
| Dec 31, 2023 | 1,055 | -355 | -25.18% | 988 | 67 |
| Dec 31, 2022 | 1,410 | 233 | 19.80% | 1,402 | 8 |
| Dec 31, 2021 | 1,177 | 210 | 21.72% | 1,167 | 10 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Caris Life Sciences | 1,846 |
| Apellis Pharmaceuticals | 739 |
| Rhythm Pharmaceuticals | 414 |
| Mirum Pharmaceuticals | 372 |
| Immunovant | 362 |
| Scholar Rock Holding | 289 |
| Cogent Biosciences | 258 |
| Celcuity | 155 |
PTCT News
- 4 hours ago - PTC Therapeutics Transcript: Study result - Transcripts
- 5 hours ago - PTC Therapeutics Reports Positive Topline Results from Month 24 Interim Analysis of PIVOT-HD Extension Study of Votoplam - PRNewsWire
- 11 hours ago - PTC Therapeutics to Report Results from PIVOT-HD Long Term Extension Study - PRNewsWire
- 6 days ago - PTC Therapeutics to Report First Quarter 2026 Financial Results on Thursday, May 7, 2026 - PRNewsWire
- 11 days ago - PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - PRNewsWire
- 4 weeks ago - PTC Therapeutics Appoints Biotech Banking Pioneer Jessica Chutter to Board of Directors - PRNewsWire
- 6 weeks ago - PTC Therapeutics Transcript: Barclays 28th Annual Global Healthcare Conference - Transcripts
- 7 weeks ago - PTC Therapeutics Transcript: Leerink Global Healthcare Conference 2026 - Transcripts